(Q42289342)

English

The effect of benzbromarone on allopurinol/oxypurinol kinetics in patients with gout

scientific article published on January 1993

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

The effect of benzbromarone on allopurinol/oxypurinol kinetics in patients with gout (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

author name string

F O Müller

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

R Schall

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

G Groenewoud

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

H K Hundt

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

J C van der Merwe

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

M van Dyk

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 1993

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

69-72

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

https://scigraph.springernature.com/pub.10.1007/bf00315283

0 references

Treatment of hyperuricaemia with a combination of allopurinol and benzbromaron (author's transl)

1 reference

https://pubmed.ncbi.nlm.nih.gov/8436158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gout, current results on pathogenesis, diagnosis and therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8436158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time course of oxipurinol levels in plasma following single dose and chronic administration of allopurinol in different pharmaceutical preparations (author's transl)

1 reference

https://pubmed.ncbi.nlm.nih.gov/8436158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal clearance of oxipurinol, the chief metabolite of allopurinol

1 reference

https://pubmed.ncbi.nlm.nih.gov/8436158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinetics of allopurinol after single intravenous and oral doses. Noninteraction with benzbromarone and hydrochlorothiazide

1 reference

https://pubmed.ncbi.nlm.nih.gov/8436158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statistical analysis of bioavailability studies: parametric and nonparametric confidence intervals

1 reference

https://pubmed.ncbi.nlm.nih.gov/8436158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reducing the risks in the treatment of gout and hyperuricaemia (author's transl)

1 reference

https://pubmed.ncbi.nlm.nih.gov/8436158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Confidence intervals rather than P values: estimation rather than hypothesis testing

1 reference

https://pubmed.ncbi.nlm.nih.gov/8436158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allopurinol kinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/8436158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uric-acid reduction with high allopurinol dosages (author's transl)

1 reference

https://pubmed.ncbi.nlm.nih.gov/8436158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic studies of allopurinol, an inhibitor of xanthine oxidase

1 reference

https://pubmed.ncbi.nlm.nih.gov/8436158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of uric acid lowering drugs in low dosage in patients with hyperuricemia and hypertriglyceridemia in a randomized group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/8436158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00315283

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42289342&oldid=1941310122"